| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_043d73c928f71744d196fbcf6ffe841c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87d6ec376252c6ae3202a61fac433e41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-567 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate |
1987-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e8be340cf8368e2d79f611479c661c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09944d26721e8026742ef0718574ee23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c135d91e1b5a604affa516df53fd40c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b583c4a288259e562a69297ecdd04d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7789e5368fed38a6db1981b8bb68812e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd2174498d194e56bff613f75269a11 |
| publicationDate |
1988-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0260599-A2 |
| titleOfInvention |
Method and agent for detecting antibodies against human and animal retroviruses, especially T-lymphotropic viruses |
| abstract |
Described are a method and means for the detection of antibodies against human and animal retroviruses, and more specifically T-lymphotropic viruses, by allowing a sample to be investigated to react with a human or animal cell line infected with said viruses and subsequently labelling by means of a second antibody directed against human antibodies bearing a marker. A cell line is used only part of the cells of which after the infection expresses viral antigens. The negatively-reacting cells are used as internal standard. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0832691-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0832691-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0349037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0495465-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102023212-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10002803-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0495465-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102023212-B |
| priorityDate |
1986-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |